house · trading 2023-02-20 → 2026-05-29
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
By recent-buy return, Max Miller ranks #28 of 122 lawmakers — better than 77% of Congress.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-05-29 | CCLFX | SELL | $15K–$50K | $10.42 | $10.34 2026-08-27 | +0.8% exit |
| 2025-08-04 | GLAS | BUY | $1K–$15K | $5.91 | $9.78 2026-08-27 | +65.6% |
| 2025-07-15 | GLAS | BUY | $647.63–$647.63 | $5.28 | $9.78 2026-08-27 | +85.2% |
| 2025-07-15 | GLAS | BUY | $15K–$50K | $5.28 | $9.78 2026-08-27 | +85.2% |
| 2025-05-08 | GLAS | BUY | $1K–$15K | $6.26 | $9.78 2026-08-27 | +56.2% |
| 2024-11-26 | GLAS | BUY | $1K–$15K | $7.21 | $9.78 2026-08-27 | +35.6% |
| 2024-11-01 | GLAS | BUY | $1K–$15K | $7.80 | $9.78 2026-08-27 | +25.4% |
| 2024-09-10 | GLAS | BUY | $1K–$15K | $9.31 | $9.78 2026-08-27 | +5.0% |
| 2024-08-22 | GLAS | BUY | $1K–$15K | $9.35 | $9.78 2026-08-27 | +4.6% |
| 2024-02-16 | GLAS | BUY | $1K–$15K | $6.80 | $9.78 2026-08-27 | +43.8% |
| 2023-10-06 | VO | SELL | $1K–$15K | $51.60 | $83.09 2026-08-27 | -61.0% exit |
| 2023-10-06 | VOO | SELL | $15K–$50K | $394.56 | $708.75 2026-08-27 | -79.6% exit |
| 2023-10-06 | JEPI | SELL | $1K–$15K | $53.01 | $57.85 2026-08-27 | -9.1% exit |
| 2023-06-29 | GLAS | BUY | $15K–$50K | $3.47 | $9.78 2026-08-27 | +181.8% |
| 2023-05-11 | MST | BUY | $1K–$15K | — | — | — |
| 2023-05-11 | GRI | BUY | $1K–$15K | $294115.63 | $2.07 2026-08-27 | -100.0% |
| 2023-02-20 | GSK | BUY | $1K–$15K | $35.88 | $50.27 2026-08-27 | +40.1% |
| MST | BUY | $1K–$15K | — | — | — | |
| GRI | BUY | $1K–$15K | — | — | — |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| David A Perdue , Jr | 1 · VOO |
| James B. Renacci | 1 · GSK |
| Thomas H Tuberville | 1 · GSK |
| Thomas R Carper | 1 · GSK |
| Virginia Foxx | 1 · GSK |
| Kevin Hern | 1 · JEPI |
| John Boozman | 1 · GSK |
| K. Michael Conaway | 1 · GSK |
| Kurt Schrader | 1 · GSK |
| David P. Roe | 1 · GSK |
| Charles J. "Chuck" Fleischmann | 1 · GSK |
| Kenny Marchant | 1 · GSK |